#420 NSGC 2026: Ambry's Whole Genome Sequencing and BillionToOne's Unity Confirm
From DNA Today: A Genetics Podcast · · 31 min
This plays from the publisher's own server. We do not host a copy.
Description
In this episode, we're coming to you from Baltimore for the National Society of Genetic Counselors (NSGC) 2026 Annual Conference! From new approaches to whole genome sequencing to the ability to analyze intact fetal cells through a pregnant person’s blood sample, we're exploring two exciting advances in genetic testing that could change how patients receive answers.
Host Kira Dineen sits down with experts from Ambry Genetics and BillionToOne to discuss new technologies unveiled at the conference, their clinical applications, and how they could improve diagnostic accuracy and accessibility.
We also celebrate Genetic Counselor Appreciation Day, highlight memorable moments from NSGC 2026, and share a special thank-you following Kira's recognition with the NSGC Leader in Community Engagement Award!
Featured Guests Thomas "TJ" Slavin Jr., MD, is the Chief Medical Officer of Ambry Genetics and a medical geneticist. He joins us to discuss Ambry Genetics' newly launched whole genome sequencing offerings, GenomeNext and GenomeReveal, and how integrating RNA analysis, pangenome references, and proactive reanalysis could help end the diagnostic odyssey for more families.
Jennifer "Jen" Hoskovec, MS, CGC, is Vice President of Medical Affairs at BillionToOne and a past president of NSGC (2014). She returns to DNA Today to introduce Unity Confirm, a new prenatal testing option that isolates and sequences intact circulating placental cells from a pregnant person’s blood to provide additional information following high-risk NIPT results.
In This Episode We Discuss Ambry Genetics: Whole Genome Sequencing, RNA Analysis, and the Pangenome
- How Tempus' acquisition of Ambry Genetics brings together tumor sequencing and germline testing capabilities.
- Why Ambry chose 2026 to launch GenomeNext and GenomeReveal and how whole genome sequencing is changing rare disease diagnostics.
- How RNA analysis can help clarify variants of uncertain significance (VUS), particularly variants that may affect RNA splicing.
- Why incorporating a human pangenome reference can improve variant detection across diverse ancestral populations and help address disparities in genetic testing.
- How Ambry's Patient for Life program proactively reanalyzes genetic data and contacts providers when new evidence leads to clinically meaningful changes.
- Why identifying dual genetic diagnoses is increasingly important and how ongoing reanalysis can reveal additional explanations for a patient's symptoms.
Clarification: Dr. Slavin referred to Tempus as 'the largest tumor sequencing company'; he intended to say 'one of the largest tumor sequencing companies.
BillionToOne: Unity Confirm and Cell-Based Prenatal Testing
- How Unity Confirm differs from traditional cell-free DNA screening by isolating intact circulating extravillous trophoblasts from a pregnant person’s blood.
- How sequencing individual placental cells can provide additional information following a high-risk NIPT result.
- Why Unity Confirm is positioned as an additional testing option rather than a replacement for diagnostic procedures such as chorionic villus sampling (CVS) or amniocentesis.
- How this technology could help patients who decline invasive testing or face geographic, financial, or gestational-age barriers to accessing diagnostic procedures.
- The limitations of analyzing a small number of cells, particularly when considering placental mosaicism and conditions such as Turner syndrome.
- How staining techniques and genetic comparisons help distinguish placental trophoblasts from maternal white blood cells.
- How genetic counselors can integrate another source of prenatal information into patient-centered conversations about screening, diagnosis, and reproductive decision-making.
Resources & Links NSGC Annual Conference National Society of Genetic Counselors (NSGC) (https://www.nsgc.org) – Learn more about NSGC, its annual conference, and resources for genetic counseling…